Last checked at 22 Sep 2011 15:10
22 September 2011
Synairgen plc ('Synairgen' or the 'Company')
Grant of options
On 21 September 2011 the board of Synairgen granted options ("Options") over 2,126,469 ordinary shares of one pence each in the capital of the Company ("Ordinary Shares") at an exercise price of one pence per Ordinary Share. The Options represent in aggregate 3.06 per cent. of the existing issued share capital.
The Options are issued under the Company's existing Long Term Incentive Plan and are exercisable between 21 September 2014 and 20 September 2021, subject to achievement of performance criteria related to the increase in the total shareholder return of the Company.
The following Options were issued to directors of the Company on 21 September 2011:
Director | Options Issued |
Richard Marsden | 538,063 |
John Ward | 489,148 |
Dr. Phillip Monk | 400,212 |
Following the issue of the Options, the interests of the directors of the Company at 21 September 2011 are as follows:
Director | Total Options Issued | Ordinary Shares | Total Interest | % of issued share capital |
Richard Marsden | 2,342,032 | 95,860 | 2,437,892 | 3.50% |
John Ward | 1,772,756 | 228,788 | 2,001,544 | 2.88% |
Dr. Phillip Monk | 1,235,971 | 18,518 | 1,254,489 | 1.80% |
Iain Buchanan | 212,765 | 92,592 | 305,357 | 0.44% |
Dr. David Campbell | - | 253,960 | 253,960 | 0.37% |
Paul Clegg | 250,000 | 184,095 | 434,095 | 0.62% |
Prof. Stephen Holgate (Note 1) | - | 852,316 | 852,316 | 1.23% |
Simon Shaw | - | 1,368,580 | 1,368,580 | 1.97% |
Note 1. The holding of Professor Stephen Holgate includes 1,923 Ordinary Shares registered in the name of Professor Holgate's wife.
For further information, please contact:
Synairgen plc Tel: + 44 (0) 23 8051 2800
Richard Marsden, Chief Executive Officer
John Ward, Finance Director
FinnCap Tel: + 44 (0) 20 7220 0500
Geoff Nash (Corporate Finance)
Stephen Norcross, Simon Starr (Corporate Broking)